Cardiocare at Home Launched by Portea, AliveCor, and NanoHealth

The #HeartSmart service is a new at-home cardiac care service offered by Portea, AliveCor, and NanoHealth.

Portea, AliveCor, and NanoHealth have joined forces to introduce #HeartSmart, an at-home cardiac care service that utilizes smart devices and software applications to deliver personalized medical care. This comprehensive service empowers patients with high-risk cardiac conditions to effectively manage their health from the comfort of their own homes.

#HeartSmart includes AliveCor's KardiaMobile 6L device, NanoHealth's technology platform, and Portea's exemplary healthcare services. AliveCor's KardiaMobile 6L enables patients to capture medical-grade ECG readings in the convenience of their homes. This portable device, combined with NanoHealth's patient-centric technology platform, provides real-time insights into cardiac health. Patients can transmit their data to healthcare professionals for analysis and monitoring, ensuring timely intervention and personalized care.

Portea, a leading healthcare provider, contributes its comprehensive care services to the #HeartSmart initiative. These services encompass doctor consultations, counseling, medication reminders, and essential diagnostic tests. Portea's skilled healthcare professionals deliver personalized attention and guidance to patients, ensuring effective management of cardiac health from the comfort and convenience of their homes.

Vaibhav Tewari, Co-founder and CEO of Portea, emphasizes the significance of personalized care in cardiac health management. He highlights the importance of initiatives like #HeartSmart in India, as they provide comprehensive cardiac care services that ensure patients receive timely care and support, regardless of their geographical location. By extending cardiac care services to patients' homes, #HeartSmart aims to bridge the gap between patients and healthcare providers, enabling convenient access to high-quality care.

Manish Ranjan, Co-founder and CEO of NanoHealth, recognizes the transformative potential of #HeartSmart in revolutionizing cardiac care. Through collaboration with AliveCor and Portea, NanoHealth aims to provide patients with a seamless and comprehensive experience in managing their cardiac health at home. By leveraging technology and expertise, #HeartSmart enables patients to take an active role in monitoring and managing their cardiac conditions. This leads to improved health outcomes.

Lokesh Prasad, Managing Director of AliveCor India, expressed excitement about the innovative collaboration. The partnership between AliveCor, Portea, and NanoHealth signifies a significant advancement in cardiac care, bringing together cutting-edge technology and specialized healthcare services. By combining their respective strengths, these companies aim to make a positive impact on cardiac care in India, empowering patients with the tools and support they need for better cardiac health management.

The introduction of #HeartSmart addresses the growing need for comprehensive cardiac care services in India. Cardiovascular diseases are a leading cause of mortality in the country, and providing accessible and personalized care is crucial for managing these conditions effectively. With the convenience of at-home monitoring and expert guidance from healthcare professionals, #HeartSmart aims to improve patient outcomes, reduce hospital visits, and enhance cardiac care quality.

It is clear that #HeartSmart, the collaborative effort between Portea, AliveCor, and NanoHealth, represents a significant leap forward in at-home cardiac care. By incorporating smart devices, software applications, and specialized healthcare services, #HeartSmart empowers patients with high-risk cardiac conditions to effectively manage their health from their homes. This comprehensive initiative aims to revolutionize cardiac care by providing real-time insights, personalized attention, and timely interventions, ultimately improving patient outcomes and transforming the cardiac care landscape in India.